Stay updated with breaking news from William Rote. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Potential for pegtibatinase to become first disease-modifying treatment for classical HCU; topline data expected in 2026SAN DIEGO, Dec. 14, 2023 -- Travere Therapeutics, Inc. today announced the...
Data from the four patients treated with the highest dose of pegtibatinase showed a clinically meaningful 67.1% mean relative reduction in total...
Data from the four patients treated with the highest dose of pegtibatinase showed a clinically meaningful 67.1% mean relative reduction in total homocysteine from baseline Pegtibatinase has... | May 31, 2023